» Articles » PMID: 16076485

The in Vitro Regulation of Ovarian Follicle Development Using Alginate-extracellular Matrix Gels

Overview
Journal Biomaterials
Date 2005 Aug 4
PMID 16076485
Citations 96
Authors
Affiliations
Soon will be listed here.
Abstract

The extracellular matrix (ECM) provides a three-dimensional structure that promotes and regulates cell adhesion and provides signals that direct the cellular processes leading to tissue development. In this report, synthetic matrices that present defined ECM components were employed to investigate these signaling effects on tissue formation using ovarian follicle maturation as a model system. In vitro systems for follicle culture are being developed to preserve fertility for women, and cultures were performed to test the hypothesis that the ECM regulates follicle maturation in a manner that is dependent on both the ECM identity and the stage of follicle development. Immature mouse follicles were cultured within alginate-based matrices that were modified with specific ECM components (e.g., laminin) or RGD peptides. The matrix maintains the in vivo like morphology of the follicle and provides an environment that supports follicle development. The ECM components signal the somatic cells of the follicle, affecting their growth and differentiation, and unexpectedly also affect the meiotic competence of the oocyte. These effects depend upon both the identity of the ECM components and the initial stage of the follicle, indicating that the ECM is a dynamic regulator of follicle development. The development of synthetic matrices that promote follicle maturation to produce meiotically competent oocytes may provide a mechanism to preserve fertility, or more generally, provide design principles for scaffold-based approaches to tissue engineering.

Citing Articles

Comparing the Effect of Heat Therapy and Mitochondrial-Targeted Antioxidants in Polycystic Ovarian Syndrome Phenotype Induced by Junk Food Consumption.

Amin S, Aolymat I, Hosny S, Latif N, Ibrahim W, ShamsEldeen A Reprod Sci. 2025; 32(2):343-357.

PMID: 39821756 DOI: 10.1007/s43032-024-01755-w.


3D-Printed Polymeric Biomaterials for Health Applications.

Zhu Y, Guo S, Ravichandran D, Ramanathan A, Sobczak M, Sacco A Adv Healthc Mater. 2024; 14(1):e2402571.

PMID: 39498750 PMC: 11694096. DOI: 10.1002/adhm.202402571.


Follicle-intrinsic and spatially distinct molecular programs drive follicle rupture and luteinization during ex vivo mammalian ovulation.

Zaniker E, Zhang J, Russo D, Huang R, Suritis K, Drake R Commun Biol. 2024; 7(1):1374.

PMID: 39443665 PMC: 11500180. DOI: 10.1038/s42003-024-07074-9.


RGD peptide promotes follicle growth through integrins αvβ3/αvβ5 in three-dimensional culture.

Matsushige C, Kitazumi K, Beaman A, Miyagi M, Tallquist M, Yamazaki Y Reproduction. 2024; 169(1.

PMID: 39441765 PMC: 11729052. DOI: 10.1530/REP-24-0151.


Developing biomedical engineering technologies for reproductive medicine.

Zhu Y, Kong B, Liu R, Zhao Y Smart Med. 2024; 1(1):e20220006.

PMID: 39188735 PMC: 11235786. DOI: 10.1002/SMMD.20220006.


References
1.
Chun S, Eisenhauer K, Minami S, Billig H, Perlas E, Hsueh A . Hormonal regulation of apoptosis in early antral follicles: follicle-stimulating hormone as a major survival factor. Endocrinology. 1996; 137(4):1447-56. DOI: 10.1210/endo.137.4.8625923. View

2.
Cukierman E, Pankov R, Stevens D, Yamada K . Taking cell-matrix adhesions to the third dimension. Science. 2001; 294(5547):1708-12. DOI: 10.1126/science.1064829. View

3.
Elvin J, Matzuk M . Mouse models of ovarian failure. Rev Reprod. 1998; 3(3):183-95. DOI: 10.1530/ror.0.0030183. View

4.
Cortvrindt R, Smitz J, van Steirteghem A . Assessment of the need for follicle stimulating hormone in early preantral mouse follicle culture in vitro. Hum Reprod. 1997; 12(4):759-68. DOI: 10.1093/humrep/12.4.759. View

5.
Burns K, Matzuk M . Minireview: genetic models for the study of gonadotropin actions. Endocrinology. 2002; 143(8):2823-35. DOI: 10.1210/endo.143.8.8928. View